Effect of a Resistance Exercise Program on IGF-1 Levels in Knee Osteoarthritis
Official title: Changes in Serum IGF-1 Levels With Resistance Exercises in Patients With Knee Osteoarthritis and Their Association With Clinical and Radiological Parameters
Run by Sisli Hamidiye Etfal Training and Research Hospital · NCT07890155 · Data updated 2026-11-12
A structured 8-week resistance exercise program is being tested to see if it changes blood IGF-1 levels and improves knee OA symptoms in adults with knee OA and metabolic traits.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 75 Years |
| Sex | All |
| Enrollment | 86 (estimated) |
| Sponsor | Sisli Hamidiye Etfal Training and Research Hospital Academic / other |
| Locations | 1 site (Istanbul, Istanbul) |
| Status | Recruiting |
| Started | June 1, 2026 |
| Main results expected | December 1, 2026 |
| Study ends | January 2027 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT07890155 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40–75 with knee OA (KL grade 2–3) who have recent knee MRI and consent to an 8-week resistance program.
✕Probably not a fit
Individuals with severe comorbidities or contraindications to resistance exercise may not experience benefit or may be excluded from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, single-center study examines whether eight weeks of resistance training alter serum IGF-1 and whether those changes relate to improvements in pain and function, as well as radiographic features. Participants include adults aged 40–75 with Kellgren-Lawrence grade 2–3 knee OA, some with metabolic syndrome characteristics. Researchers will compare pre- and post-intervention IGF-1, clinical scores (WOMAC, VAS), and MOAKS osteophyte scores to explore potential associations and the modifying effect of the metabolic phenotype. The trial is non-randomized and non-blinded, with participants allocated into two predefined groups based on phenotype. The lead site is in Istanbul, Turkey, at Sisli Hamidiye Etfal Training and Research Hospital.
Why it matters
Potential benefit: If successful, the study could clarify a biochemical link between resistance exercise and OA symptom relief mediated by IGF-1, informing tailored rehabilitation strategies.
How similar studies have gone: Previous work suggests resistance exercise can influence biomarkers and symptoms in knee OA, but this specific IGF-1–metabolic phenotype interaction is an area of ongoing investigation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of knee osteoarthritis according to the American College of Rheumatology (ACR) clinical and radiographic criteria. * Radiological severity of Kellgren-Lawrence (KL) grade 2 or 3 on standing anteroposterior knee radiographs * Having a knee magnetic resonance imaging (MRI) scan obtained within the past 1 year * Age between 40 and 75 years * Volunteering to participate in the study and signing the informed consent form Exclusion Criteria: * Receiving intra-articular injections (e.g., corticosteroids, hyaluronic acid, PRP) in the affected knee within the last 6 months * History of previous major knee surgery, knee arthroplasty, or lower extremity trauma affecting biomechanics * Diagnosis of rheumatoid arthritis, or other inflammatory joint diseases * Presence of severe cardiovascular, neurological, or musculoskeletal disorders that would contraindicate or prevent participation in a structured resistance exercise program * History of malignancy or presence of active malignancy * Presence of active infection * Cognitive impairment or inability to understand and follow the exercise instructions and questionnaires
Where it's running
-
Sisli Hamidiye Etfal Training and Research Hospital
Istanbul, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Kadriye Banu Kuran, MD, Prof. — Sisli Hamidiye Etfal Training and Research Hospital
- Study coordinator: Bora Şahin, MD, PMR resident physician
- Email: borashn55@gmail.com
- Phone: +905386673139
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
SVF cellular mix, secretome, and knee response in osteoarthritis
This study tests the cellular composition and secretome of research-only adipose-derived SVF in adults with knee OA who are already planned to receive an autologous SVF injection as part of their care.
-
2-mm subchondral drilling vs sequential 4-mm and 2-mm drilling during CARTISTEM implantation for knee cartilage defects
This study tests whether drilling the knee with a 2-mm drill alone works as well as sequential 4-mm then 2-mm drilling when combined with CARTISTEM treatment for medial knee cartilage defects.
-
Undenatured Type II Collagen for Knee Osteoarthritis Pain (Three-Arm Trial)
This study tests whether taking undenatured type II collagen capsules once daily for 4 months can reduce knee pain in adults with knee osteoarthritis, compared with two collagen formulations and a placebo.
-
Preoperative Carbohydrate Drink Before Bariatric Surgery in Metabolic Syndrome
This trial tests whether drinking a carbohydrate beverage before bariatric surgery helps speed up recovery of digestion in adults with metabolic syndrome.
-
Personalized Living Plan to Improve Metabolic Health in Adults with Metabolic Syndrome
This pilot study tests a personalized lifestyle plan—time-restricted eating, more activity, a low-glycemic diet, and better sleep—to see if it can improve insulin resistance in adults with metabolic syndrome.
-
Serum Fetuin‑A and COMP levels in knee osteoarthritis
This study tests whether levels of Fetuin‑A and COMP in the blood relate to how severe knee osteoarthritis is in patients compared with healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.